Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. [electronic resource]
Producer: 20030925Description: 1459-66 p. digitalISSN:- 1538-3598
- Anti-Bacterial Agents -- therapeutic use
- Antibodies, Bacterial -- blood
- Azithromycin -- therapeutic use
- Chlamydophila Infections -- complications
- Chlamydophila pneumoniae -- immunology
- Coronary Disease -- microbiology
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- complications
- Proportional Hazards Models
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.